Caricamento...
Sputum Desmosine During Hospital Admission for Pulmonary Exacerbation in Cystic Fibrosis
BACKGROUND: Cystic fibrosis (CF) lung disease is characterized by structural changes in the airways and parenchyma. No sputum biomarker exists to measure the degree of active structural destruction during pulmonary exacerbation in patients with CF. The noninvasive measurement of desmosine, a breakdo...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American College of Chest Physicians
2009
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2789924/ https://ncbi.nlm.nih.gov/pubmed/19567495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.09-0217 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|